Article
Aldo-keto reductase 1B: Much learned, much more to do
2023-12-16
Abstract excerpt
The Aldo-Keto Reductase 1B (AKR1B) subfamily was initially known for its association with the pathogenesis of secondary diabetic complications such as retinopathy, neuropathy, nephropathy, and cataracts. Unfortunately, over the past few decades, all drug development efforts targeting this family have failed for one reason or another. Recently, a growing body of evidence showing the deep involvement of AKR1B in met...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f4aeaddd-4772-5e14-b47f-e9e1ba3cb384
- DOI
- 10.1016/j.hlife.2023.12.002
